Business Overview

Business Overview

EPS Innovative Medicine (Japan) Limited is currently engaged in the business management and support of group companies and the promotion of our research department. Specific drug candidates/technologies that we own, and their business details are as follows.

  • EPS Innovative Medicine (Japan) Limited manages and supports the business of FEF Pharmaceutical Co., Ltd., which is conducting clinical development with the aim of obtaining marketing authorization as a licensee of drug candidates/technologies originated by academia.
  • EPS Innovative Medicine (Japan) Limited manages and supports the business of EPD Co., Ltd., aiming to create value of brown fat-cell introduction technology, originated by academia, as a licensee.
  • Based on the idea that the septic IgA affects not only allergic diseases but also defense against the new coronavirus, its R&D Center is focusing on its significance and pursuing the possibility of sublingual vaccines.

Contact Us

For more information,
please feel free to contact us from below.